CO-CRYSTAL
An Overview of Pharmaceutical Co-Crystal
8
Crystal structure of the co crystal of 5 aminoisophthalic acid and 1,2 bis(pyridin 4 yl)ethene
11
Redetermined structure of 4,4′ bipyridine–1,4 phenylenediacetic acid (1/1) co crystal
7
Crystal structure of a 2:1 piroxicam–gentisic acid co crystal featuring neutral and zwitterionic piroxicam molecules
14
A 1:2 co crystal of 2,2′ thiodibenzoic acid and triphenylphosphane oxide: crystal structure, Hirshfeld surface analysis and computational study
22
Crystal and molecular structures of two silver(I) amidinates, including an unexpected co crystal with a lithium amidinate
19
Partial charge transfer in the salt co crystal of L ascorbic acid and 4,4′ bipyridine
10
Rerefinement of the co crystal of 4 hydroxypyridine with 4 hydroxypyridinium nitrate
5
Solubility Enhancement of Co-Crystal Based Solid Dosage Form.
145
A 1:2 co crystal of isonicotinamide and propionic acid
11
Crystal structure of the co crystal salt 2 amino 6 bromopyridinium 2,3,5,6 tetrafluorobenzoate
8
A 1:1 energetic co-crystal formed between trinitrotoluene and 2,3-diaminotoluene
10
A 1:2 co crystal of 2,2′ dithiodibenzoic acid and benzoic acid: crystal structure, Hirshfeld surface analysis and computational study
11
A co crystal of 1,10 phenanthroline with boric acid: a novel aza aromatic complex
9
Hydrogen bonding patterns in 5 fluorocytosine–melamine co crystal (4/1)
10
Hydrogen bonded co crystal structure of benzoic acid and zwitterionic L proline
7
A 2:1 co crystal of 3,5 dibromo 4 cyanobenzoic acid and anthracene
8
The crystal structure of the zwitterionic co crystal of 2,4 dichloro 6 {[(3 hydroxypropyl)azaniumyl]methyl}phenolate and 2,4 dichlorophenol
9
The 1:1 co crystal of 2 bromonaphthalene 1,4 dione and 1,8 dihydroxyanthracene 9,10 dione: crystal structure and Hirshfeld surface analysis
14
Crystal structure of the co crystal butylparaben–isonicotinamide (1/1)
7